F-star Biotechnology Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • F-star Biotechnology's estimated annual revenue is currently $11.2M per year.(i)
  • F-star Biotechnology's estimated revenue per employee is $155,000

Employee Data

  • F-star Biotechnology has 72 Employees.(i)
  • F-star Biotechnology grew their employee count by -43% last year.

F-star Biotechnology's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
CFOReveal Email/Phone
3
VP, Clinical DevelopmentReveal Email/Phone
4
VP, Business Development & Corporate StrategyReveal Email/Phone
5
SVP Corporate Operations & PeopleReveal Email/Phone
6
VP, Finance and corporate controllerReveal Email/Phone
7
Head HRReveal Email/Phone
8
SVP, Head ResearchReveal Email/Phone
9
Head Business Operations and EA to the Head F-starReveal Email/Phone
10
Director, GCP QualityReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is F-star Biotechnology?

F-star is a clinical-stage biopharmaceutical company committed to delivering life-changing treatments to cancer patients. Through our highly efficient Modular Antibody Technology platform, we are building and progressing an extensive immuno-oncology pipeline of mAb², a novel class of disruptive bispecific antibodies designed to unlock new biology which cannot be achieved by combining monospecific drugs. F-star's technological expertise and scientific approach have been validated through strategic partnerships with leaders in the pharma and biotech industries. Find out more at www.f-star.com.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

72

Number of Employees

$11.2M

Revenue (est)

-43%

Employee Growth %

N/A

Valuation

N/A

Accelerator

F-star Biotechnology News

2022-04-17 - Comparing Quantum Genomics Société Anonyme (OTCMKTS ...

... F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH,...

2022-03-22 - F-star Therapeutics Appoints James Sandy as Chief ...

... and biotechnology industries across all phases of drug development. Before joining F-star Therapeutics James served as Chief Development...

2020-12-03 - F-star Therapeutics Announces First Patient Dosed in First-in-Class FS120 Phase 1 Clinical Trial

CAMBRIDGE, England and CAMBRIDGE, Mass., Dec. 3, 2020 /PRNewswire/ -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announces that the first pati ...

2020-10-22 - F-star Therapeutics to Present at SITC 2020 Virtual Annual Meeting

CAMBRIDGE, England and CAMBRIDGE, Mass., Oct. 22, 2020 /PRNewswire/ -- F-star Therapeutics Ltd., a clinical-stage immuno-oncology company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announced t ...

2017-06-05 - F-star expands its relationship with Merck through a new strategic collaboration

F-star expands its relationship with Merck through a new strategic collaboration 05-06-2017 F-star, a biopharmaceutical company developing novel bispecific antibodies, announces today a new partnership with Merck, a leading science and technology company, for the development and commercialisat ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.1M72-21%N/A
#2
$11.2M723%N/A
#3
$11.2M726%N/A
#4
$9.4M7213%N/A
#5
$7.5M7233%N/A